ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO842

Promoting Kidney Health Equity through Kidney Disease Screening and Awareness Program at University of Virginia

Session Information

Category: Diversity and Equity in Kidney Health

  • 900 Diversity and Equity in Kidney Health

Authors

  • Greig, Morgan, UVA Health, Charlottesville, Virginia, United States
  • Nguyen, Joseph D., UVA Health, Charlottesville, Virginia, United States
  • Shah, Monarch, UVA Health, Charlottesville, Virginia, United States
  • Malhotra, Rakesh, University of California San Diego Department of Medicine, La Jolla, California, United States
  • Chopra, Tushar, UVA Health, Charlottesville, Virginia, United States
Background

Kidney Disease Screening and Awareness Program (KDSAP) at University of Virginia (UVA) aims to promote kidney health awareness and improve outcomes among vulnerable populations. Our community health events employed questionnaires and screening tests to assess community prevalence and awareness of hypertension (HTN), diabetes (DM), and isolated proteinuria among participants based on self-reported race and gender.

Methods

Self-reported race, gender, and screening results were obtained from the KDSAP at UVA database from 2022 to 2024. Reported race was White, Black, Asian, Hispanic, or Latin(o). Reported gender was male, female, or other. Positive HTN screen was defined as blood pressure above 130/80 mm Hg, positive DM screen was defined as fasting blood glucose ≥126 mg/dL, and positive proteinuria screen was defined as urine albumin creatinine ratio (UACR) above 30 mg/g. A patient-reported screening questionnaire obtained the percentage of participants unaware of their condition.

Results

Of the 92 patients in the KDSAP database, the frequency of a positive screening test was 48.9% for HTN, 10.1% for DM, and 32.2% for proteinuria. Positive HTN screening rate was particularly prevalent among self-reported males (52.8%), Blacks (64%), and Asians (64.7%), with unawareness rates of 67.9%, 25%, and 81%, respectively (Table 1). Positive proteinuria screen rate was 30-40% amongst males, females, whites, and blacks, and approximately 80-100% of total participants were unaware of proteinuria.

Conclusion

In summary, the majority of patients screened positive on at least one test, and many of these patients were unaware of their condition. Our data suggests that there are significant cultural and socioeconomic barriers to care that prevent vulnerable populations from taking advantage of preventive interventions, both medical and educational, for chronic conditions such as HTN, DM, and CKD. We improved patient awareness and provided educational materials with the goal of leading to positive behavioral changes. Our study highlights the need for long-term primary care and nephrology follow-up for patients who screened positive.

 MaleFemaleWhiteBlackAsianHispanic/Latin(o)
 % Pos Screen% Pos Unaware of Cond.% Pos Screen% Pos Unaware of Cond.% Pos Screen% Pos Unaware of Cond.% Pos Screen% Pos Unaware of Cond.% Pos Screen% Pos Unaware of Cond.% Pos Screen% Pos Unaware of Cond.
HTN536846563675642565824090
Proteinuria308831833610040801210028100
DM111786714043318334100